WASHINGTON, July 30 -- Food and Drug Administration has issued a notice called: Butylated Hydroxytoluene (BHT); Request for Information; Reopening of Comment Period.
The notice was published in the Federal Register on July 30 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or we) is reopening the comment period for the notice titled "Butylated Hydroxytoluene (BHT); Request for Information, " which published in the Federal Registerof May 13, 2026. We are taking this action in response to a request from stakeholders to extend the comment period to allow additional time for interested parties to develop and submit data, other information, and comments ...